Literature DB >> 8869195

Relationship between clinical severity of respiratory syncytial virus infection and subtype.

M C Kneyber1, A H Brandenburg, P H Rothbarth, R de Groot, A Ott, H A van Steensel-Moll.   

Abstract

The relationship between clinical severity of respiratory syncytial virus (RSV) infection and distribution of subtype A or B was investigated. The data of 232 children, who were admitted with RSV infection or diagnosed in the outpatient department of the Sophia Children's Hospital, Rotterdam between 1992 and 1995, were studied. The diagnosis of RSV was confirmed by a direct immunofluorescence assay. Subtyping was performed by an indirect immunofluorescence assay using specific monoclonal antibodies. Gender, age at diagnosis, gestational age and birth weight, the presence of underlying diseases, feeding difficulties, the presence of wheezing and retractions, respiratory rate, temperature, clinical diagnosis at presentation, oxygen saturation (SaO2), carbon dioxide tension (PCO2), and pH, characteristics of hospitalisation, and the need for mechanical ventilation were observed. Analysis was performed on data from all patients diagnosed with RSV infection in the period between 1992 and 1995 spanning three RSV seasons, and separately on the RSV season 1993-4. The outcome of the three year analysis (150 (64.7%) subtype A v 82 (35.3%) subtype B) was compared with the outcome of the season 1993-4, a mixed epidemic with 37 (60.7%) subtype A and 24 (39.3%) subtype B isolates. None of the variables observed in the season 1993-4 differed significantly between RSV subtype A and B. Similar results were obtained from the analysis in the period 1992 until 1995, with the exception of PCO2 (a higher PCO2 was found in subtype A, p < 0.001) and retractions (more retractions were noted in patients with subtype A, p = 0.03). After correcting for possible confounders using regression analysis, these differences were not significant anymore. The data indicate that there is no relationship between clinical severity of RSV infection and subtype.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8869195      PMCID: PMC1511617          DOI: 10.1136/adc.75.2.137

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  13 in total

1.  Occurrence of groups A and B of respiratory syncytial virus over 15 years: associated epidemiologic and clinical characteristics in hospitalized and ambulatory children.

Authors:  C B Hall; E E Walsh; K C Schnabel; C E Long; K M McConnochie; S W Hildreth; L J Anderson
Journal:  J Infect Dis       Date:  1990-12       Impact factor: 5.226

Review 2.  The respiratory syncitial virus and its role in acute bronchiolitis.

Authors:  M L Everard; A D Milner
Journal:  Eur J Pediatr       Date:  1992-09       Impact factor: 3.183

Review 3.  Respiratory syncytial virus puzzle: clinical features, pathophysiology, treatment, and prevention.

Authors:  W V La Via; M I Marks; H R Stutman
Journal:  J Pediatr       Date:  1992-10       Impact factor: 4.406

4.  Comparative virulence of respiratory syncytial virus subgroups A and B.

Authors:  C E Taylor; S Morrow; M Scott; B Young; G L Toms
Journal:  Lancet       Date:  1989-04-08       Impact factor: 79.321

5.  Antigenic characterization of respiratory syncytial virus strains with monoclonal antibodies.

Authors:  L J Anderson; J C Hierholzer; C Tsou; R M Hendry; B F Fernie; Y Stone; K McIntosh
Journal:  J Infect Dis       Date:  1985-04       Impact factor: 5.226

6.  Epidemiology of respiratory syncytial virus infection in Washington, D.C. II. Infection and disease with respect to age, immunologic status, race and sex.

Authors:  R H Parrott; H W Kim; J O Arrobio; D S Hodes; B R Murphy; C D Brandt; E Camargo; R M Chanock
Journal:  Am J Epidemiol       Date:  1973-10       Impact factor: 4.897

7.  American Academy of Pediatrics Committee on Infectious Diseases: Ribavirin therapy of respiratory syncytial virus.

Authors: 
Journal:  Pediatrics       Date:  1987-03       Impact factor: 7.124

8.  Comparison of direct and indirect immunofluorescence staining of clinical specimens for detection of respiratory syncytial virus antigen.

Authors:  L L Minnich; C G Ray
Journal:  J Clin Microbiol       Date:  1982-05       Impact factor: 5.948

9.  Clinical findings and severity of acute bronchiolitis.

Authors:  E K Mulholland; A Olinsky; F A Shann
Journal:  Lancet       Date:  1990-05-26       Impact factor: 79.321

10.  Respiratory syncytial virus (RSV) bronchiolitis: comparative study of RSV groups A and B infected children.

Authors:  S M Straliotto; B Roitman; J B Lima; G B Fischer; M M Siqueira
Journal:  Rev Soc Bras Med Trop       Date:  1994 Jan-Mar       Impact factor: 1.581

View more
  20 in total

1.  Novel inflammatory markers, clinical risk factors and virus type associated with severe respiratory syncytial virus infection.

Authors:  Christy M Tabarani; Cynthia A Bonville; Manika Suryadevara; Patrick Branigan; Dongliang Wang; Danning Huang; Helene F Rosenberg; Joseph B Domachowske
Journal:  Pediatr Infect Dis J       Date:  2013-12       Impact factor: 2.129

2.  Differential immune responses and pulmonary pathophysiology are induced by two different strains of respiratory syncytial virus.

Authors:  Nicholas W Lukacs; Martin L Moore; Brian D Rudd; Aaron A Berlin; Robert D Collins; Sandra J Olson; Samuel B Ho; R Stokes Peebles
Journal:  Am J Pathol       Date:  2006-09       Impact factor: 4.307

3.  Local variability in respiratory syncytial virus disease severity.

Authors:  A H Brandenburg; P Y Jeannet; H A Steensel-Moll; A Ott; P H Rothbarth; W Wunderli; S Suter; H J Neijens; A D Osterhaus; C A Siegrist
Journal:  Arch Dis Child       Date:  1997-11       Impact factor: 3.791

4.  Respiratory Syncytial Virus Genotypes, Host Immune Profiles, and Disease Severity in Young Children Hospitalized With Bronchiolitis.

Authors:  Rosa Rodriguez-Fernandez; Lorena I Tapia; Chin-Fen Yang; Juan Pablo Torres; Susana Chavez-Bueno; Carla Garcia; Lisa M Jaramillo; Melissa Moore-Clingenpeel; Hasan S Jafri; Mark E Peeples; Pedro A Piedra; Octavio Ramilo; Asuncion Mejias
Journal:  J Infect Dis       Date:  2017-12-27       Impact factor: 5.226

5.  Respiratory syncytial virus genotypes and disease severity among children in hospital.

Authors:  J N Fletcher; R L Smyth; H M Thomas; D Ashby; C A Hart
Journal:  Arch Dis Child       Date:  1997-12       Impact factor: 3.791

6.  Clinical Profiles of Respiratory Syncytial Virus Subtypes A AND B Among Children Hospitalized with Bronchiolitis.

Authors:  Federico R Laham; Jonathan M Mansbach; Pedro A Piedra; Kohei Hasegawa; Ashley F Sullivan; Janice A Espinola; Carlos A Camargo
Journal:  Pediatr Infect Dis J       Date:  2017-08       Impact factor: 2.129

7.  G protein variation in respiratory syncytial virus group A does not correlate with clinical severity.

Authors:  A H Brandenburg; R van Beek; H A Moll; A D Osterhaus; E C Claas
Journal:  J Clin Microbiol       Date:  2000-10       Impact factor: 5.948

8.  Respiratory virus-induced regulation of asthma-like responses in mice depends upon CD8 T cells and interferon-gamma production.

Authors:  Joost J Smit; Louis Boon; Nicholas W Lukacs
Journal:  Am J Pathol       Date:  2007-11-08       Impact factor: 4.307

9.  Distribution and seasonality of rhinovirus and other respiratory viruses in a cross-section of asthmatic children in Trinidad, West Indies.

Authors:  Jason Matthew; Lexley M Pinto Pereira; Tressa E Pappas; Cheri A Swenson; Kris A Grindle; Kathy A Roberg; Robert F Lemanske; Wai-Ming Lee; James E Gern
Journal:  Ital J Pediatr       Date:  2009-06-25       Impact factor: 2.638

10.  Molecular epidemiology and disease severity of human respiratory syncytial virus in Vietnam.

Authors:  Dinh Nguyen Tran; Thi Minh Hong Pham; Manh Tuan Ha; Thi Thu Loan Tran; Thi Kim Huyen Dang; Lay-Myint Yoshida; Shoko Okitsu; Satoshi Hayakawa; Masashi Mizuguchi; Hiroshi Ushijima
Journal:  PLoS One       Date:  2013-01-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.